Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shonda A. Foster, Bridget L. Balkaran, M. Janelle Cambron-Mellott, Karen Samaan, Oksana Mason, Wenyu Ye, John C. Rowland & Dena H. Jaffe. (2021) Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study. Current Medical Research and Opinion 37:3, pages 443-457.
Read now
Read now
Articles from other publishers (4)
Andreia Ferreira, Sofia Reis Marques, Sofia Lopes, Ricardo Maré, Gisela Carneiro, Margarida Lopes & Sara Varanda. (2022) Preventive Oral Treatment in Migraine: Efficacy and Dropout Rates Observed at a Tertiary Headache Center. SN Comprehensive Clinical Medicine 5:1.
Crossref
Crossref
Paolo Martelletti. 2022. Migraine in Medicine. Migraine in Medicine
639
881
.
Juanzhi Fang, Stephanie Korrer, Jonathan C. Johnson, Mark A. Cheadle, Roshani Shah, Matias L. Ferraris & Cristina Lopez-Lopez. (2021) Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis. Advances in Therapy 38:6, pages 2921-2934.
Crossref
Crossref
Marianna Delussi, Eleonora Vecchio, Giuseppe Libro, Silvia Quitadamo & Marina de Tommaso. (2020) Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center. BMC Neurology 20:1.
Crossref
Crossref